Navigation Links
Global Mercury Treaty May Include Ban on Mercury in Medicine
Date:8/1/2011

SILVER SPRING, Md., Aug. 1, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, July 22, 2011, the United Nations Environment Programme (UNEP) distributed a revised text for its comprehensive global treaty on mercury.  Advocates for mercury-free drugs were gratified to see pharmaceuticals listed in "Annex C (Mercury-added product not allowed)" of the proposed treaty.

The Coalition for Mercury-free Drugs (CoMeD) helped initiate this addition through its advocacy efforts at the United Nations (UN) negotiations held in Chiba, Japan, in January 2011.  CoMeD President Rev. Lisa Sykes, the mother of a son diagnosed with vaccine-related mercury poisoning, described to representatives of over 150 participating nations how:  "... unnecessarily injecting mercury into pregnant women and children, as part of a vaccine or other drug, is an ongoing and often unrecognized crisis."

Thimerosal (49.6% mercury by weight), still used as a vaccine preservative and in-process sterilizing agent, is an unnecessary, and sometimes undisclosed, component in many vaccines.  Its use is associated with neurodevelopmental disorders, cancer, birth defects and miscarriage.  Those harmed most by Thimerosal in vaccines are the unborn and newborn.

Addressing the diplomats attending the UN meeting in Chiba, Dr. Mark R. Geier of CoMeD observed: "For this treaty to be fully effective, it must make clear that the intentional exposure of humans, especially pregnant women and young children, to mercury, will not be tolerated."  

Dr. Geier's comments were especially well-received by the diplomats from developing nations.  CoMeD representatives met with regional working groups in closed-door sessions and explained the feasibility of using 2-phenoxyethanol, a much less toxic alternative to Thimerosal, in vaccines and other drugs.

Dr. Geier challenged the inequity of providing wealthy nations with vaccines having reduced levels of mercury while poor nations still receive vaccines containing dangerously high levels of mercury: "Children around the world, no matter their place of birth or their income level, deserve safe mercury-free vaccines.  The practice of providing mercury-reduced and mercury-free vaccines to developed countries while insisting that developing nations take mercury-containing ones is wrong."

By the end of negotiations in Chiba, diplomats from developing countries requested the Secretariat to assess the safety of mercury in drugs.  

A team of scientists and advocates from CoMeD will attend the next treaty negotiation in Nairobi, Kenya, from October 31 through November 4, 2011, to support keeping this global ban on mercury-containing drugs in the finalized UN treaty.


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Insulin- Global
2. Global Diagnostic Imaging (CT, MRI, X-Ray & Ultrasound) Market - Competitive Landscape & Forecasts From 2010 to 2016
3. MarketsandMarkets: Global Diagnostic Imaging Market Estimated to Reach $26.6 Billion by 2016
4. Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies
5. Orthopaedics: Market Prospects & Global Competition
6. 4th Alzheimers Awards Announced in Search of Global Solutions for Better Dementia Care
7. Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited
8. Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference
9. Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil™
10. Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011
11. Flow Cytometry: Products, Technologies and Global Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):